Adenosine A3 receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis

Biomedicine and Pharmacotherapy

Volumn 61, Issue 6, 2007, Pages 356-359

  Hofer, Michal ^a   Pospíšil, Milan ^a   Znojil, Vladimír ^b   Holá, Jiřina ^a   Vacek, Antonín ^a   Štreitová, Denisa ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Adenosine A3 receptor; Cell proliferation; Hematopoiesis

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR AGONIST; FLUOROURACIL;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HEMATOPOIESIS; HOMEOSTASIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADENOSINE; ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL LINEAGE; CELL PROLIFERATION; ERYTHROID CELLS; GRANULOCYTES; HEMATOPOIESIS; HOMEOSTASIS; MALE; MICE; MICE, INBRED STRAINS; RECEPTOR, ADENOSINE A3;

EID: 34547547657     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.02.010     Document Type: Article

References (16)

1. Abbracchio M.P. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res 39 (1996) 393
2. Schulte G., and Fredholm B.B. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15 (2003) 813
3. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., and Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Arch Pharmacol 362 (2000) 364
4. Pospíšil M., Hofer M., Znojil V., Vácha J., Netíková J., and Holá J. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood 86 (1995) 3692
5. Hofer M., Pospíšil M., Netíková J., Znojil V., and Vácha J. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine act additively to enhance the hemopoietic spleen colony formation in irradiated mice. Physiol Res 48 (1999) 37
6. Pospíšil M., Hofer M., Vacek A., Netíková J., Holá J., Znojil V., et al. Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil. Exp Hematol 29 (2001) 557
7. Hofer M., Pospíšil M., Znojil V., Vacek A., Weiterová L., Holá J., et al. Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factor. Eur J Haematol 68 (2002) 4
8. Fishman P., Bar-Yehuda S., Farbstein T., Barer F., and Ohana G. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors. J Cell Physiol 183 (2000) 393
9. Bar-Yehuda S., Madi L., Barak D., Mittelman M., Ardon E., Ochaion A., et al. Agonists to the A3 adenosine receptor induce G-CSF production via NF-κB activation: a new class of myeloprotective agents. Exp Hematol 30 (2002) 1390
10. Pospíšil M., Hofer M., Vacek A., Znojil V., and Pipalová I. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil. Physiol Res 53 (2004) 549
11. Hofer M., Pospíšil M., Vacek A., Holá J., Znojil V., Weiterová L., et al. Effects of adenosine A3 receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice. Eur J Pharmacol 538 (2006) 163
12. Newby A.C. Adenosine and the concept of "retaliatory metabolites". Trends Biochem Sci 9 (1984) 42
13. Dougherty C., Barucha J., Schofield P.R., Jacobson K.A., and Liang B.T. Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 and A3 receptor. FASEB J 1998 (1785) 12
14. Dhalla A.K., Shryock J.C., Shreeniwas R., and Belardinelli L. Pharmacology and therapeutic applications of A1 adenosine receptor ligands. Curr Top Med Chem 3 (2003) 369
15. Madi L., Ochaion A., Rath-Wolfson L., Bar-Yehuda S., Erlanger A., Ohana G., et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10 (2004) 4472
16. Fishman P., and Bar-Yehuda S. Pharmacology and therapeutic applications of A3 receptor subtype. Curr Top Med Chem 3 (2003) 463